Rob Faulkner

Powered by the world’s first FDA-cleared truly contactless patient monitoring system, Circadia improves clinical outcomes through early detection. The technology monitors a patient’s respiratory rate from up to 8 feet away without anything on the bed or body. Clinicians use this data to identify medical events such as Congestive Heart Failure, COPD Exacerbations, Pneumonia, Sepsis, UTIs, and Falls — several hours and days in advance. A team of virtual nurses review data from the device and analyze trends in the patient’s electronic health record to deliver personalized, predictive risk alerts 24/7/365.

Our mission is to transform access to excellent care. For more than a decade, our team has helped organizations better care for their people with access to the best providers in the nation because we believe that there should not be a trade-off between affordable care and excellent care. As a market-leading healthcare services business, we provide high-quality and cost-efficient solutions for self-funded employers and their employees. Our solutions transform healthcare for our members, facilitating access to top-quality care at fair prices nationwide. Our SurgeryPlus® solution is the leading center of excellence (COE) for surgery. The accessibility of our network, utilization, savings, and outcomes are what sets SurgeryPlus apart from all other COEs. Our solution is also integrated into the benefits ecosystem to ensure utilization and a simplified experience for members. Dedicated Care Advocates guide members to our highly distributed network of individually selected, excellent surgeons, taking care of them at every step throughout their journey. But steering members within our network, we reduce complication rates and lower plan costs, in turn allowing employers to waive the employee cost share, increasing the affordability of care, and improving health equity. We’ve also launched Cancer Care Direct™, the first end-to-end cancer care solution. Our oncology nurse-led program is designed to guide the member from their initial diagnosis through active treatment and beyond ensuring access to excellent care where and when they need it. Where possible, we keep members close to home with excellent local community oncology care while ensuring they have access to both virtual and in-person care at the top national oncology centers of excellence.

MedAvail Inc. is the developer of the MedCenter automated dispensing and medication management technologies. The company designs and manufactures pharmacist-controlled automated prescription medicine dispensing vaults, similar in appearance to ATMs. Intended for deployment in hospitals, pharmacies, medical clinics, and other locations. The company integrates advanced robotics, two-way video teleconferencing, and a secure network for patients medical information to create a prescription medication dispensing system.

Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders. The company’s first product, the Evoke® System, is the only ECAP-controlled closed-loop spinal cord stimulation (SCS) system and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain. The Evoke System instantaneously reads, records, and responds to the nerves’ response to stimulation to provide continually optimized therapy and is proven to be superior to open-loop SCS for the treatment of overall trunk and/or limb pain. 12-month results from the EVOKE Study, the first double-blind randomized controlled trial (RCT) used in support of Premarket Approval (PMA) in spinal cord stimulation history, were published in The Lancet Neurology and 24-month results have since been published JAMA Neurology. Both studies are poised to set new clinical standards for long-term pain relief and improvements in physical and emotional functioning, sleep quality and health-related quality of life. In the EU, Evoke is CE Marked and commercially available. In the U.S., Evoke is FDA-approved and will be available when the Company implements its full commercial release in 2023. Saluda Medical is a privately held company with headquarters in Artarmon, New South Wales, Australia and has offices in Bloomington, MN, USA; Harrogate, UK; and Terheijden, Netherlands. To learn more about Saluda Medical, including the risks & important safety information, visit www.saludamedical.com.

We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.

Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners. Augmedix is on a mission to help clinicians and patients form a human connection at the point of care with seamless technology. Augmedix’s proprietary Notebuilder Platform extracts relevant data from natural clinician-patient conversations and converts that data into medical notes in real time, which are seamlessly transferred to the EHR. The company’s platform uses Automatic Speech Recognition, Natural Language Processing including Large Language Models, and medical documentation specialists to generate accurate and timely medical notes. Leveraging this platform, Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of clinician-patient interactions and analyzing them to deliver actionable insights that elevate patient care. Augmedix saves clinicians up to 3 hours per day, improves productivity by as much as 20%, and increases satisfaction with work-life balance by over 40%. Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.

Impulse Dynamics is dedicated to improving the lives of people with heart failure and is the developer of the innovative Optimizer®CCM® therapy delivery system. CCM® therapy is a breakthrough heart failure treatment that is proven to improve quality of life for heart failure patients. CCM® therapy is specifically designed to improve contraction of the heart in an effort to deliver more oxygen-rich blood to the body. CCM® therapy is a safe and effective minimally invasive treatment option for millions of heart failure patients who otherwise have few or no effective options available to them Optimizer was granted Breakthrough Device designation by the FDA and is the first and only FDA-approved device in the U.S. or elsewhere for the delivery of CCM® therapy. For important safety info visit: http://bit.ly/303mFRN

Genalyte is a tech-enabled, full service CAP accredited and CLIA certified laboratory. We perform the majority of tests with our rapidly deployable mobile laboratory in under 30 minutes. Our central lab handles tests that cannot be performed onsite. All results are run through CloudLab, our proprietary tele-health platform, for quality oversight and monitoring by Clinical Lab Scientists. Core to our mobile capabilities is the Maverick platform, which has unprecedented serological testing functionality - permitting up to 64 simultaneous immunoassays on whole blood in 15 minutes. The platform achieved FDA clearance in Oct 2019. In these unprecedented times, we have developed a rapid COVID-19 serology test for IgG and IgM antibodies, while simultaneously including flu and other respiratory illnesses for differential diagnosis. For more information, visit www.genalyte.com.

Encapsulating Biology, Transforming Discovery. #SphereFluidics is developing picodroplets and single cell analysis systems and services for therapeutic discovery.

Powered by the world’s first FDA-cleared truly contactless patient monitoring system, Circadia improves clinical outcomes through early detection. The technology monitors a patient’s respiratory rate from up to 8 feet away without anything on the bed or body. Clinicians use this data to identify medical events such as Congestive Heart Failure, COPD Exacerbations, Pneumonia, Sepsis, UTIs, and Falls — several hours and days in advance. A team of virtual nurses review data from the device and analyze trends in the patient’s electronic health record to deliver personalized, predictive risk alerts 24/7/365.